Palatin Technologies (FRA:PTN) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:PTN Palatin Technologies Inc FRA:PTN
19 GF Score
Price €3.30
! 5 Warning Signs
View Full Analysis

What is Palatin Technologies Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

FRA:PTN
19GF Score
Palatin Technologies Inc FRA:PTN
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Palatin Technologies Business Description

Other Exchanges PTN:USA0KF3:UK
Address 103 Carnegie Center Drive, Suite 300, Princeton, NJ, USA, 08852
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. The Company's business is in one operating segment: life science.
19GF Score

Get the complete analysis for FRA:PTN

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.30
Price